<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet9505</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-9505</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original paper</subject></subj-group></article-categories><title-group><article-title>Влияние массы и характера распределения жировой ткани на содержание лeптина у беременных в различные сроки гестации</article-title><trans-title-group xml:lang="en"><trans-title>Influence of mass and distribution of adipose tissue on the content of leptin in pregnant women at different periods gestations</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3173-021X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чабанова</surname><given-names>Наталья Борисовна</given-names></name><name name-style="western" xml:lang="en"><surname>Chabanova</surname><given-names>Natalya B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент кафедры акушерства и гинекологии</p></bio><bio xml:lang="en"><p>MD, PhD, associate professor </p></bio><email xlink:type="simple">Natalya.Chabanova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Василькова</surname><given-names>Татьяна Николаевна</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilkova</surname><given-names>Tatiana N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, проректор по учебно-методической работе, профессор кафедры госпитальной терапии с курсом эндокринологии и фтизиатрии</p></bio><bio xml:lang="en"><p>MD, ScD, professor</p></bio><email xlink:type="simple">vasilkovatn@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полякова</surname><given-names>Валентина Анатольевна</given-names></name><name name-style="western" xml:lang="en"><surname>Polyakova</surname><given-names>Valentina A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующая кафедрой акушерства и гинекологии</p></bio><bio xml:lang="en"><p>MD, ScD, professor, head of the Department of Obstetrics and Gynecology</p></bio><email xlink:type="simple">polycova_gyn@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матаев</surname><given-names>Сергей Иванович</given-names></name><name name-style="western" xml:lang="en"><surname>Mataev</surname><given-names>Sergey I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, директор ООО Многопрофильной клиники "Лимфомед"</p></bio><bio xml:lang="en"><p>MD, ScD, professor</p></bio><email xlink:type="simple">mataevci@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБОУ ВО &amp;laquo;Тюменский государственный медицинский университет&amp;raquo; Минздрава России&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Tyumen State Medical University&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>&lt;p&gt;ООО &amp;laquo;Многопрофильный медицинский центр "Лимфомед"&amp;raquo;&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Мultiprofile medical center "Limfomed"&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2019</year></pub-date><volume>16</volume><issue>1</issue><fpage>55</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чабанова Н.Б., Василькова Т.Н., Полякова В.А., Матаев С.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Чабанова Н.Б., Василькова Т.Н., Полякова В.А., Матаев С.И.</copyright-holder><copyright-holder xml:lang="en">Chabanova N.B., Vasilkova T.N., Polyakova V.A., Mataev S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/9505">https://www.omet-endojournals.ru/jour/article/view/9505</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Ожирение в настоящее время является одной из наиболее значимых проблем здравоохранения во всем мире. Свойственное ожирению избыточное накопление жировой ткани сопровождается метаболическими нарушениями, в том числе повышенной секрецией лептина, способствующими, в свою очередь, увеличению риска гестационных осложнений.</p></sec><sec><title>Цель</title><p>Цель. Оценить уровень лептина в сыворотке крови беременных в зависимости от массы тела, массы и характера распределения жировой ткани в различные сроки гестации.</p></sec><sec><title>Методы</title><p>Методы. Объектом исследования явились 211 женщин с одноплодной беременностью, наступившей в естественном цикле и завершившейся срочными родами. Всем женщинам проводились антропометрическое исследование, оценка массы жировой ткани методом биоимпедансометрии, характера жироотложения с помощью УЗИ жировой ткани, определение уровня сывороточного лептина в сроке 10–14, 24–28 и 36–38 нед беременности.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что уровень сывороточного лептина нарастает пропорционально предгестационному индексу массы тела у всех беременных начиная с I триместра. Женщины с избыточной массой тела и ожирением на протяжении всего гестационного периода имели достоверно более высокие концентрации лептина, чем при нормальной массе тела (р&lt;0,001). С увеличением срока беременности мы наблюдали рост уровня сывороточного лептина во всех группах независимо от характера жироотложения. К концу III триместра женщины с нормальной массой тела имели наибольшую величину абсолютной и относительной прибавки массы тела и жировой массы, что сопровождалось увеличением концентрации лептина более чем в 3 раза по отношению к предгестационному уровню.</p></sec><sec><title>Заключение</title><p>Заключение. Таким образом, более высокое содержание лептина в сыворотке крови беременных с избыточной массой тела и ожирением в I триместре объясняется избыточным накоплением жировой ткани. Наибольшая величина гестационной прибавки массы тела и жировой массы в группе женщин с нормальным исходным весом сопровождается значительным увеличением уровня лептина на единицу массы тела и жировой массы. Эти данные свидетельствуют, что контроль и ограничение чрезмерной прибавки веса в период беременности может являться мерой профилактики избыточной секреции лептина и связанных с этим гестационных осложнений.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Currently, obesity is one of the most global problem in the world. Redundant accumulation of adipose tissue accompanied by metabolic disorders including high secretion of leptin may lead to an increased risk of gestational complications. </p></sec><sec><title>AIMS</title><p>AIMS: To assess the level of leptin in pregnant women’s blood serum depending on their body weight and the character of content of adipose tissue in different terms of gestation.</p></sec><sec><title>MATERIALS AND METHODS</title><p>MATERIALS AND METHODS: We investigated 211 women with single pregnancies, which came in natural cycles and finished with urgent parturitions. All of them got anthropometric study, assessment of adipose tissue’s weight by bioimpedanceometry, character of fat deposition by ultrasound investigation of adipose tissue, determination of the level of whey leptin at 10–14, 24–28, 36–38 weeks of pregnancy. </p></sec><sec><title>RESULTS</title><p>RESULTS: Established, that the level of leptin increases in proportion to pregestational body mass index from the first trimester. Women with excess body mass and with obesity had higher concentrations of leptin all over gestation, than women with normal body mass (р&lt;0.001). The higher term of pregnancy was, the higher the level of whey leptin was in all groups, independently of character of fat deposition. In the end of third trimester, women with normal body mass had the largest value of absolute and relative increase of body mass and fatty mass, what accompanied by enlargement of the concentration of leptin more than in 3 times for the pregestational level.</p></sec><sec><title>CONCLUSIONS</title><p>CONCLUSIONS: In this way, high content of leptin in pregnant women’s (with excess body mass and obesity) blood serum in the first trimester is explained by redundant accumulation of the adipose tissue. The largest value of gestational increase of body mass and fat mass in group where women had normal initial weight is accompanied by the great increase of the level of leptin on the body weight unit and fat mass. These data indicate, that control and limitation of excessive weight gain while pregnancy can be a measure of prevention of the redundant leptin’s secretion and different gestational complications related with it.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>ожирение</kwd><kwd>лептин</kwd><kwd>жировая ткань</kwd><kwd>подкожный жир</kwd><kwd>висцеральный жир</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>obesity</kwd><kwd>leptin</kwd><kwd>adipose tissue</kwd><kwd>subcutaneous fat</kwd><kwd>visceral fat</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Behnes M, Brueckmann M, Lang S, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis. 2012;12(1):217. doi: 10.1186/1471-2334-12-217</mixed-citation><mixed-citation xml:lang="en">Behnes M, Brueckmann M, Lang S, et al. Alterations of leptin in the course of inflammation and severe sepsis. BMC Infect Dis. 2012;12(1):217. doi: 10.1186/1471-2334-12-217</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Pérez A, Sánchez-Jiménez F, Maymó J, et al. Role of leptin in female reproduction. Clin Chem Lab Med. 2015;53(1):15-28. doi: 10.1515/cclm-2014-0387</mixed-citation><mixed-citation xml:lang="en">Pérez-Pérez A, Sánchez-Jiménez F, Maymó J, et al. Role of leptin in female reproduction. Clin Chem Lab Med. 2015;53(1):15-28. doi: 10.1515/cclm-2014-0387</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Петунина Н.А., Кузина И.А. Роль гормонов жировой ткани в развитии осложнений беременности у женщин с ожирением // Ожирение и метаболизм. – 2013. – Т.10. – №1 – С.3–8. [Petunina NA, Kuzina IA. The role of hormones of adipose tissue in the development pregnancy complications in obese women. Ožirenie i metabolizm. 2013;10(1):3-8. (In Russ.)] doi: 10.14341/2071-8713-2013-1</mixed-citation><mixed-citation xml:lang="en">Петунина Н.А., Кузина И.А. Роль гормонов жировой ткани в развитии осложнений беременности у женщин с ожирением // Ожирение и метаболизм. – 2013. – Т.10. – №1 – С.3–8. [Petunina NA, Kuzina IA. The role of hormones of adipose tissue in the development pregnancy complications in obese women. Ožirenie i metabolizm. 2013;10(1):3-8. (In Russ.)] doi: 10.14341/2071-8713-2013-1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Суплотова Л.А., Сметанина С.А., Плотников Н.В., Мурычева К.А. Клинико-метаболические и молекулярно-генетические ассоциации у женщин репродуктивного возраста при инсулинорезистентности, ожирении и метаболическом синдроме // Медицинская наука и образование Урала. – 2013. – Т.14. – №2. – С.84-87. [Suplotova LA, Smetanina SA, Plotnikov NV, Muricheva KA. Associations of clinical, metabolic and molecular genetic markers of insulin resistance for womens of reproductive age with obesity and metabolic syndrome. Medicinskaâ nauka i obrazovanie Urala. 2013;14(2):84-87. (InRuss.)]</mixed-citation><mixed-citation xml:lang="en">Суплотова Л.А., Сметанина С.А., Плотников Н.В., Мурычева К.А. Клинико-метаболические и молекулярно-генетические ассоциации у женщин репродуктивного возраста при инсулинорезистентности, ожирении и метаболическом синдроме // Медицинская наука и образование Урала. – 2013. – Т.14. – №2. – С.84-87. [Suplotova LA, Smetanina SA, Plotnikov NV, Muricheva KA. Associations of clinical, metabolic and molecular genetic markers of insulin resistance for womens of reproductive age with obesity and metabolic syndrome. Medicinskaâ nauka i obrazovanie Urala. 2013;14(2):84-87. (InRuss.)]</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029-1033. doi: 10.1038/nm0997-1029</mixed-citation><mixed-citation xml:lang="en">Masuzaki H, Ogawa Y, Sagawa N, et al. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029-1033. doi: 10.1038/nm0997-1029</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Pérez A, Toro A, Vilariño-García T, et al. Leptin action in normal and pathological pregnancies. J Cell Mol Med. 2017;22(2):716-727. doi: 10.1111/jcmm.13369</mixed-citation><mixed-citation xml:lang="en">Pérez-Pérez A, Toro A, Vilariño-García T, et al. Leptin action in normal and pathological pregnancies. J Cell Mol Med. 2017;22(2):716-727. doi: 10.1111/jcmm.13369</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Горбатенко Н.В., Беженарь В.Ф., Фишман М.Б. Влияние ожирения на развитие нарушения репродуктивной функции у женщин (аналитический обзор литературы) // Ожирение и метаболизм. – 2017. – Т.14. – №.1 – С.3-8. [Gorbatenko NV, Bezhenar VF, Fishman MB. Obesity and reproductive health of women. Ožirenie i metabolism. 2017;14(1):3-8. (In Russ.)] doi: 10.14341/OMET201713-8</mixed-citation><mixed-citation xml:lang="en">Горбатенко Н.В., Беженарь В.Ф., Фишман М.Б. Влияние ожирения на развитие нарушения репродуктивной функции у женщин (аналитический обзор литературы) // Ожирение и метаболизм. – 2017. – Т.14. – №.1 – С.3-8. [Gorbatenko NV, Bezhenar VF, Fishman MB. Obesity and reproductive health of women. Ožirenie i metabolism. 2017;14(1):3-8. (In Russ.)] doi: 10.14341/OMET201713-8</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Чабанова Н.Б., Матаев С.И., Василькова Т.Н., Трошина И.А. Метаболические нарушения при адипоцитокиновом дисбалансе и гестационные осложнения // Ожирение и метаболизм. – 2017. – Т.14. – №.1 – С.9-16. [Chabanova NB, Mataev SI, Vasilkova TN, Troshina IA. Metabolic disorders in adipocytokine imbalance and gestational complications. Ožirenie i metabolism. 2017;14(1):9-16. (In Russ.)] doi: 10.14341/OMET201719-16</mixed-citation><mixed-citation xml:lang="en">Чабанова Н.Б., Матаев С.И., Василькова Т.Н., Трошина И.А. Метаболические нарушения при адипоцитокиновом дисбалансе и гестационные осложнения // Ожирение и метаболизм. – 2017. – Т.14. – №.1 – С.9-16. [Chabanova NB, Mataev SI, Vasilkova TN, Troshina IA. Metabolic disorders in adipocytokine imbalance and gestational complications. Ožirenie i metabolism. 2017;14(1):9-16. (In Russ.)] doi: 10.14341/OMET201719-16</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor BD, Ness RB, Olsen J, et al. Serum Leptin Measured in Early Pregnancy Is Higher in Women With Preeclampsia Compared With Normotensive Pregnant Women. Hypertension. 2015;65(3):594-599. doi: 10.1161/HYPERTENSIONAHA.114.03979</mixed-citation><mixed-citation xml:lang="en">Taylor BD, Ness RB, Olsen J, et al. Serum Leptin Measured in Early Pregnancy Is Higher in Women With Preeclampsia Compared With Normotensive Pregnant Women. Hypertension. 2015;65(3):594-599. doi: 10.1161/HYPERTENSIONAHA.114.03979</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Pérez A, Guadix P, Maymó J, et al. Insulin and Leptin Signaling in Placenta from Gestational Diabetic Subjects. Horm Metab Res. 2015;48(01):62-69. doi: 10.1055/s-0035-1559722</mixed-citation><mixed-citation xml:lang="en">Pérez-Pérez A, Guadix P, Maymó J, et al. Insulin and Leptin Signaling in Placenta from Gestational Diabetic Subjects. Horm Metab Res. 2015;48(01):62-69. doi: 10.1055/s-0035-1559722</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Pérez A, Maymó J, Gambino Y, et al. Activated Translation Signaling in Placenta from Pregnant Women with Gestational Diabetes Mellitus: Possible Role of Leptin. Horm Metab Res. 2013;45(06):436-442. doi: 10.1055/s-0032-1333276</mixed-citation><mixed-citation xml:lang="en">Pérez-Pérez A, Maymó J, Gambino Y, et al. Activated Translation Signaling in Placenta from Pregnant Women with Gestational Diabetes Mellitus: Possible Role of Leptin. Horm Metab Res. 2013;45(06):436-442. doi: 10.1055/s-0032-1333276</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91(1073):151-162. doi: 10.1136/postgradmedj-2014-132672</mixed-citation><mixed-citation xml:lang="en">Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91(1073):151-162. doi: 10.1136/postgradmedj-2014-132672</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zidan HE, Rezk NA, Alnemr AAA, Moniem MIA. Interleukin-17 and leptin genes polymorphisms and their levels in relation to recurrent pregnancy loss in Egyptian females. Immunogenetics. 2015;67(11-12):665-673. doi: 10.1007/s00251-015-0876-8</mixed-citation><mixed-citation xml:lang="en">Zidan HE, Rezk NA, Alnemr AAA, Moniem MIA. Interleukin-17 and leptin genes polymorphisms and their levels in relation to recurrent pregnancy loss in Egyptian females. Immunogenetics. 2015;67(11-12):665-673. doi: 10.1007/s00251-015-0876-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Salem H, Rosenfeld T, Altarescu G, Grisaru-Granovsky S, Birk R. Maternal and neonatal leptin and leptin receptor polymorphisms associated with preterm birth. Gene. 2016;591(1):209-213. doi: 10.1016/j.gene.2016.07.014</mixed-citation><mixed-citation xml:lang="en">Salem H, Rosenfeld T, Altarescu G, Grisaru-Granovsky S, Birk R. Maternal and neonatal leptin and leptin receptor polymorphisms associated with preterm birth. Gene. 2016;591(1):209-213. doi: 10.1016/j.gene.2016.07.014</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lausten-Thomsen U, Christiansen M, Hedley PL, Holm J-C, Schmiegelow K. Adipokines in umbilical cord blood from children born large for gestational age. J Pediatr Endocrinol Metab. 2016;29(1):33-37. doi: 10.1515/jpem-2014-0502</mixed-citation><mixed-citation xml:lang="en">Lausten-Thomsen U, Christiansen M, Hedley PL, Holm J-C, Schmiegelow K. Adipokines in umbilical cord blood from children born large for gestational age. J Pediatr Endocrinol Metab. 2016;29(1):33-37. doi: 10.1515/jpem-2014-0502</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol. 2009;160(3):337-347. doi: 10.1530/EJE-08-0621</mixed-citation><mixed-citation xml:lang="en">Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrinol. 2009;160(3):337-347. doi: 10.1530/EJE-08-0621</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Щербаков В.И., Поздняков И.М., Ширинская А.В., Волков М.В. Изучение уровня энергетического регулятора лептина и хемокина сxсl8 в условиях угрозы преждевременных родов и при преэклампсии // Сибирский научный медицинский журнал. 2015. – Т.35. – №6. – С.52-55. [Shcherbakov VI, Pozdnyakov IM, Shirinskaya AV, Volkov MV. Studying of energy balance regulators – leptin and CXCL8 chemokin levels under condition of premature birth threatening and at preeclampsia. Sibirskij naučnyj medicinskij žurnal. 2017;35(6):52-55. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Щербаков В.И., Поздняков И.М., Ширинская А.В., Волков М.В. Изучение уровня энергетического регулятора лептина и хемокина сxсl8 в условиях угрозы преждевременных родов и при преэклампсии // Сибирский научный медицинский журнал. 2015. – Т.35. – №6. – С.52-55. [Shcherbakov VI, Pozdnyakov IM, Shirinskaya AV, Volkov MV. Studying of energy balance regulators – leptin and CXCL8 chemokin levels under condition of premature birth threatening and at preeclampsia. Sibirskij naučnyj medicinskij žurnal. 2017;35(6):52-55. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Д.В. Николаев, А.В. Смирнов, И.Г. Бобринская, С.Г. Руднев. Биоимпедансный анализ состава тела человека. – М: Наука, 2009. [Nikolaev DV, Smirnov AV, Bobrinskaya IG, Rudnev S.G. Bioelectric impedance analysis of human body composition. Moscow: Nauka; 2009. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Д.В. Николаев, А.В. Смирнов, И.Г. Бобринская, С.Г. Руднев. Биоимпедансный анализ состава тела человека. – М: Наука, 2009. [Nikolaev DV, Smirnov AV, Bobrinskaya IG, Rudnev S.G. Bioelectric impedance analysis of human body composition. Moscow: Nauka; 2009. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tayama K, Inukai T, Shimomura Y. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1999;43(1):49-58. doi: 10.1016/S0168-8227(98)00118-1</mixed-citation><mixed-citation xml:lang="en">Tayama K, Inukai T, Shimomura Y. Preperitoneal fat deposition estimated by ultrasonography in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1999;43(1):49-58. doi: 10.1016/S0168-8227(98)00118-1</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Armellini F, Zamboni M, Rigo L, et al. The contribution of sonography to the measurement of intra-abdominal fat. J Clin Ultrasound. 1990;18(7):563-567. doi: 10.1002/jcu.1870180707</mixed-citation><mixed-citation xml:lang="en">Armellini F, Zamboni M, Rigo L, et al. The contribution of sonography to the measurement of intra-abdominal fat. J Clin Ultrasound. 1990;18(7):563-567. doi: 10.1002/jcu.1870180707</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med. 1993;95(3):309-314. doi: 10.1016/0002-9343(93)90284-V</mixed-citation><mixed-citation xml:lang="en">Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med. 1993;95(3):309-314. doi: 10.1016/0002-9343(93)90284-V</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537-1545. doi: 10.1016/j.ajog.2005.06.064</mixed-citation><mixed-citation xml:lang="en">Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537-1545. doi: 10.1016/j.ajog.2005.06.064</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Naylor C, Petri WA. Leptin Regulation of Immune Responses. Trends Mol Med. 2016;22(2):88-98. doi: 10.1016/j.molmed.2015.12.001</mixed-citation><mixed-citation xml:lang="en">Naylor C, Petri WA. Leptin Regulation of Immune Responses. Trends Mol Med. 2016;22(2):88-98. doi: 10.1016/j.molmed.2015.12.001</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Pérez A, Maymó J, Gambino Y, et al. Leptin Stimulates Protein Synthesis-Activating Translation Machinery in Human Trophoblastic Cells1. Biol Reprod. 2009. doi: 10.1095/biolreprod.109.076513</mixed-citation><mixed-citation xml:lang="en">Pérez-Pérez A, Maymó J, Gambino Y, et al. Leptin Stimulates Protein Synthesis-Activating Translation Machinery in Human Trophoblastic Cells1. Biol Reprod. 2009. doi: 10.1095/biolreprod.109.076513</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Панков Ю.А. Лептин и его медиаторы в регуляции жирового обмена // Ожирение и метаболизм. – 2010. – Т.7. – №2. – С.3-9. [Pankov YA. Leptin and its mediators in the regulation of lipid metabolism. Ožirenie i metabolism. 2010;7(2):3-9. (In Russ.)] doi: 10.14341/2071-8713-5202</mixed-citation><mixed-citation xml:lang="en">Панков Ю.А. Лептин и его медиаторы в регуляции жирового обмена // Ожирение и метаболизм. – 2010. – Т.7. – №2. – С.3-9. [Pankov YA. Leptin and its mediators in the regulation of lipid metabolism. Ožirenie i metabolism. 2010;7(2):3-9. (In Russ.)] doi: 10.14341/2071-8713-5202</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47(6):913-917. doi: 10.2337/diabetes.47.6.913</mixed-citation><mixed-citation xml:lang="en">Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47(6):913-917. doi: 10.2337/diabetes.47.6.913</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнова Е.Н., Шулькина С.Г. Содержание лептина, растворимых рецепторов лептина и индекса свободного лептина у больных с метаболическим синдромом // Ожирение и метаболизм. – 2017. – Т.14. – №.1 – С.30-34. [Smirnova EN, Shulkina SG. Leptin, soluble leptin receptor and the free leptin index in patients with metabolic syndrome. Ožirenie i metabolism. 2017;14(1):30-34. (In Russ.)] doi: 10.14341/OMET2017130-34</mixed-citation><mixed-citation xml:lang="en">Смирнова Е.Н., Шулькина С.Г. Содержание лептина, растворимых рецепторов лептина и индекса свободного лептина у больных с метаболическим синдромом // Ожирение и метаболизм. – 2017. – Т.14. – №.1 – С.30-34. [Smirnova EN, Shulkina SG. Leptin, soluble leptin receptor and the free leptin index in patients with metabolic syndrome. Ožirenie i metabolism. 2017;14(1):30-34. (In Russ.)] doi: 10.14341/OMET2017130-34</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Lönnqvist F, Nordfors L, Jansson M, Thörne A, Schalling M, Arner P. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest. 1997;99(10):2398-2404. doi: 10.1172/JCI119422</mixed-citation><mixed-citation xml:lang="en">Lönnqvist F, Nordfors L, Jansson M, Thörne A, Schalling M, Arner P. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J Clin Invest. 1997;99(10):2398-2404. doi: 10.1172/JCI119422</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
